Food and Staples Retailing
Company Overview of New England Compounding Pharmacy, Inc.
New England Compounding Pharmacy, Inc., a compounding-only pharmacy, provides compounded medications and services to patients and prescribers. It offers specialty medications for hospitals in the areas of interventional pain management, radiology/nuclear medicine, surgery, ophthalmology, emergency, miscellaneous, retina, and aesthetics. The company was incorporated in 1998 and is based in Framingham, Massachusetts.
697 Waverly Street
Framingham, MA 01702
Founded in 1998
Key Executives for New England Compounding Pharmacy, Inc.
New England Compounding Pharmacy, Inc. does not have any Key Executives recorded.
New England Compounding Pharmacy, Inc. Key Developments
Victims of Contaminated Steroid Injections to Share $100 Million Settlement Against New England Compounding Center, Attorneys with Janet, Jenner & Suggs
May 6 14
Victims of contaminated steroid injections who sued in federal courts will share a $100 million settlement against the New England Compounding Center (NECC), attorneys with Janet, Jenner & Suggs, LLC. The settlement was tentatively agreed upon last December. It was officially filed with the bankruptcy court, which must approve it. The bankruptcy court is overseeing NECC's bankruptcy, filed in 2012. The settlement is with NECC, NECC's owners, related companies, and insurers. The Case is In re: New England Compounding Pharmacy Inc. Products Liability Litigation, MDL No. 2419, in the U.S. Judicial Panel on Multidistrict Litigation (MDL). The announced settlement covers all claims against NECC filed in with the bankruptcy claims administrator.
Plaintiffs' Steering Committee Announces Settlement with the Owners, Operators and Insurers of the New England Compounding Pharmacy, Inc
Dec 23 13
The Court-appointed Plaintiffs' Steering Committee (PSC), charged with speaking for hundreds of victims of tainted steroids produced by the New England Compounding Pharmacy, Inc. announced a preliminary settlement with the owners, operators and insurers of the bankrupt NECC. A conditional agreement has been reached between bankruptcy trustee Paul D. Moore, the PSC and the Unsecured Creditors Committee under which the Cadden and Conigliaro families, the insurers of NECC and related company Ameridose, have promised to pay to a compensation fund an amount that may exceed $100 million. This fund will allow victims who received injections of tainted steroids made by NECC to seek a measure of justice against those wrongdoers. The agreements are not final, require due diligence on the part of the PSC to ensure the rights to victims are protected under these agreements, and will be conditional upon approval by creditors and a federal court for fairness and adequacy.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|